PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17988958-0	2008	Fenretinide prevents the development of osteoporosis in Cftr-KO mice.	Fenretinide	0-11	cystic fibrosis transmembrane conductance regulator	Mus musculus	56-60	
17988958-4	2008	In this study, we characterized the protective effect of fenretinide [N-(4-hydroxyphenyl) retinamide], a vitamin A derivative, on the early onset of osteoporosis in cystic fibrosis transmembrane conductance regulator knockout (Cftr-KO) mice.	Fenretinide	57-68	cystic fibrosis transmembrane conductance regulator	Mus musculus	165-216	
17988958-4	2008	In this study, we characterized the protective effect of fenretinide [N-(4-hydroxyphenyl) retinamide], a vitamin A derivative, on the early onset of osteoporosis in cystic fibrosis transmembrane conductance regulator knockout (Cftr-KO) mice.	Fenretinide	57-68	cystic fibrosis transmembrane conductance regulator	Mus musculus	227-231	
17988958-4	2008	In this study, we characterized the protective effect of fenretinide [N-(4-hydroxyphenyl) retinamide], a vitamin A derivative, on the early onset of osteoporosis in cystic fibrosis transmembrane conductance regulator knockout (Cftr-KO) mice.	Fenretinide	70-100	cystic fibrosis transmembrane conductance regulator	Mus musculus	165-216	
17988958-4	2008	In this study, we characterized the protective effect of fenretinide [N-(4-hydroxyphenyl) retinamide], a vitamin A derivative, on the early onset of osteoporosis in cystic fibrosis transmembrane conductance regulator knockout (Cftr-KO) mice.	Fenretinide	70-100	cystic fibrosis transmembrane conductance regulator	Mus musculus	227-231	
32306138-2	2020	Our study aimed to investigate the age-dependent deterioration in lung function and the effects of treatment with Fenretinide formulation (LAU-7b) in Cftr knockout (KO) mice.	Fenretinide	114-125	cystic fibrosis transmembrane conductance regulator	Mus musculus	150-154	
17656682-6	2008	Since it has been previously reported that in vitro treatment with fenretinide induced ceramide in neuroblastoma cell lines, we decided to test this drug in vivo using our Cftr-knockout mice in an attempt to correct this newly identified defect in ceramide levels.	Fenretinide	67-78	cystic fibrosis transmembrane conductance regulator	Mus musculus	172-176	
17656682-8	2008	We further assessed the biological effect of fenretinide on the ability of Cftr-knockout mice to combat lung infection with P. aeruginosa.	Fenretinide	45-56	cystic fibrosis transmembrane conductance regulator	Mus musculus	75-79